Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable

被引：33

作者：

Cosentino, Francesco ^{[1
,2
]}

Ceriello, Antonio ^{[3
,4
,5
]}

Baeres, Florian ^{[6
]}

Fioretto, Paola ^{[7
]}

Garber, Alan ^{[8
]}

Stough, Wendy Gattis ^{[9
]}

George, Jyothis T. ^{[10
]}

Grant, Peter J. ^{[11
]}

Khunti, Kamlesh ^{[12
]}

Langkilde, Anna Maria ^{[13
]}

Plutz, Jorge ^{[14
]}

Ryden, Lars ^{[15
]}

Scheen, Andre ^{[16
]}

Standl, Eberhard ^{[17
]}

Tuomilehto, Jaakko ^{[18
,19
,20
]}

Zannad, Faiez ^{[21
,22
,23
,24
]}

机构：

[1] Karolinska Inst, Dept Med Solna, Cardiol Unit, Stockholm, Sweden

[2] Karolinska Univ Hosp, Stockholm, Sweden

[3] IDIBAPS, Barcelona, Spain

[4] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain

[5] IRCCS MultiMed, Dept Cardiovasc & Metab Dis, Sesto San Giovanni, Italy

[6] Novo Nordisk AS, Soborg, Denmark

[7] Univ Padua, Dept Med, Padua, Italy

[8] Baylor Coll Med, Houston, TX 77030 USA

[9] Campbell Univ, Coll Pharm & Hlth Sci, Cary, NC USA

[10] Boehringer Ingelheim Int Pharma GmbH & Co KG, Ingelheim, Germany

[11] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England

[12] Diabet Res Ctr, Leicester, Leics, England

[13] AstraZeneca, Gothenburg, Sweden

[14] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[15] Karolinska Inst, Dept Med, K2, Stockholm, Sweden

[16] Univ Liege, Div Diabet Nutr & Metab Disorders, Div Clin Pharmacol, CHU Liege, Liege, Belgium

[17] Munich Helmholtz Ctr, Forschergrp Diabet eV, Munich, Germany

[18] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland

[19] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland

[20] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia

[21] CHRU, INSERM, Ctr Invest Clin 1433, Nancy, France

[22] CHRU, INSERM, U1116, Nancy, France

[23] Univ Lorraine, Nancy, France

[24] F CRIN INI CRCT, Nancy, France

来源：

EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 34期

关键词：

IMPAIRED GLUCOSE-TOLERANCE; BASE-LINE CHARACTERISTICS; MYOCARDIAL-INFARCTION; CLINICAL ENDOCRINOLOGISTS; AMERICAN ASSOCIATION; OUTCOMES TRIALS; DISEASE; MORTALITY; EVENTS; ROSIGLITAZONE;

D O I：

10.1093/eurheartj/ehy677

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2907 / 2919

页数：13

共 67 条

[1] Cardioprotective anti-hyperglycaemic medications: a review of clinical trials [J].

Ahmed, Haitham M. ;

Khraishah, Haitham ;

Cho, Leslie .

EUROPEAN HEART JOURNAL, 2018, 39 (25) :2368-+

[2] Achievement of Goals in U.S. Diabetes Care, 1999-2010 [J].

Ali, Mohammed K. ;

Bullard, Kai McKeever ;

Saaddine, Jinan B. ;

Cowie, Catherine C. ;

Imperatore, Giuseppina ;

Gregg, Edward W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17) :1613-1624

[3] Introduction [J].

不详 .

DIABETES CARE, 2017, 40 :S1-S130

[4] Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes [J].

Anyanwagu, Uchenna ;

Mamza, Jil ;

Mehta, Rajnikant ;

Donnelly, Richard ;

Idris, Iskandar .

HEART, 2016, 102 (19) :1581-1587

[5] Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project [J].

Arnold, Suzanne V. ;

Inzucchi, Silvio E. ;

Tang, Fengming ;

McGuire, Darren K. ;

Mehta, Sanjeev N. ;

Maddox, Thomas M. ;

Goyal, Abhinav ;

Sperling, Laurence S. ;

Einhorn, Daniel ;

Wong, Nathan D. ;

Khunti, Kamlesh ;

Lam, Carolyn S. P. ;

Kosiborod, Mikhail .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (15) :1637-1645

[6] Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II [J].

Beckman, Joshua A. ;

Paneni, Francesco ;

Cosentino, Francesco ;

Creager, Mark A. .

EUROPEAN HEART JOURNAL, 2013, 34 (31) :2444-U31

[7]

Boehringer Ingelheim International GmbH, 2018, JARDIANCE FULL PRESC

[8] Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials [J].

Boussageon, Remy ;

Supper, Irene ;

Bejan-Angoulvant, Theodora ;

Kellou, Nadir ;

Cucherat, Michel ;

Boissel, Jean-Pierre ;

Kassai, Behrouz ;

Moreau, Alain ;

Gueyffier, Francois ;

Cornu, Catherine .

PLOS MEDICINE, 2012, 9 (04)

[9] Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV) [J].

Cannon, Christopher P. ;

Mcguire, Darren K. ;

Pratley, Richard ;

Dagogo-Jack, Sam ;

Mancuso, James ;

Huyck, Susan ;

Charbonnel, Bernard ;

Shih, Weichung J. ;

Gallo, Silvina ;

Masiukiewicz, Urszula ;

Golm, Gregory ;

Cosentino, Francesco ;

Lauring, Brett ;

Terra, Steven G. .

AMERICAN HEART JOURNAL, 2018, 206 :11-23

[10] Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum [J].

Cefalu, William T. ;

Kaul, Sanjay ;

Gerstein, Hertzel C. ;

Holman, Rury R. ;

Zinman, Bernard ;

Skyler, Jay S. ;

Green, Jennifer B. ;

Buse, John B. ;

Inzucchi, Silvio E. ;

Leiter, Lawrence A. ;

Raz, Itamar ;

Rosenstock, Julio ;

Riddle, Matthew C. .

DIABETES CARE, 2018, 41 (01) :14-31

← 1 2 3 4 5 6 7 →